The role of ecto-5′-nucleotidase in endothelial dysfunction and vascular pathologies

Pharmacological Reports

Volumn 67, Issue 4, 2015, Pages 675-681

  Zukowska, Paulina ^a   Kutryb Zajac, Barbara ^a   Toczek, Marta ^a   Smolenski, Ryszard T ^a   Slominska, Ewa M ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Adenosine; Ecto 5 nucleotidase; Endothelium; Inflammation; Vascular pathologies

Indexed keywords

5' NUCLEOTIDASE; ECTO 5' NUCLEOTIDASE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; NT5E PROTEIN, HUMAN;

ARTERY CALCIFICATION; ATHEROSCLEROSIS; CELL FUNCTION; CELL STRUCTURE; ENDOTHELIAL DYSFUNCTION; GRAFT REJECTION; HUMAN; INFLAMMATION; NONHUMAN; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; UPREGULATION; VASCULAR DISEASE; XENOTRANSPLANTATION; ANIMAL; ENZYMOLOGY; PATHOLOGY; PHYSIOLOGY; VASCULAR DISEASES; VASCULAR ENDOTHELIUM; VASODILATATION;

5'-NUCLEOTIDASE; ANIMALS; ENDOTHELIUM, VASCULAR; GPI-LINKED PROTEINS; HUMANS; VASCULAR DISEASES; VASODILATION;

EID: 84940460502     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: 10.1016/j.pharep.2015.05.002     Document Type: Review

References (65)

1. L. Antonioli, P. Pacher, E.S. Vizi, and G. Haskó CD39 and CD73 in immunity and inflammation Trends Mol Med 19 2013 355 367
2. G.G. Yegutkin Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade Biochim Biophys Acta 1783 2008 673 694
3. N. Sträter Ecto-5′-nucleotidase: structure function relationships Purinergic Signal 2 2006 343 350
4. V. Bianchi, and J. Spychala Mammalian 5′-nucleotidases J Biol Chem 278 2003 46195 46198
5. A. Borowiec, K. Lechward, K. Tkacz-Stachowska, and A.C. Składanowski Adenosine as a metabolic regulator of tissue function: production of adenosine by cytoplasmic 5′-nucleotidases Acta Biochim Pol 53 2006 269 278
6. M.R. Klemens, W.R. Sherman, N.J. Holmberg, J.M. Ruedi, M.G. Low, and L.F. Thompson Characterization of soluble vs membrane-bound human placental 5′-nucleotidase Biochem Biophys Res Commun 172 1990 1371 1377
7. H. Zimmermann, M. Zebisch, and N. Sträter Cellular function and molecular structure of ecto-nucleotidases Purinergic Signal 8 2012 437 502
8. S. James, and P.J. Richardson Production of adenosine from extracellular atp at the striatal cholinergic synapse J Neurochem 60 1993 219 227
9. L.F. Thompson, H.K. Eltzschig, J.C. Ibla, C.J. Van De Wiele, R. Resta, J.C. Morote-Garcia, and et al. Crucial role for ecto-5′-nucleotidase (CD73) in vascular leakage during hypoxia J Exp Med 200 2004 1395 1405
10. M. Toczek, B. Kutryb-Zając, M. Kapczyńska, M. Lipiński, E.M. Słomińska, and R.T. Smoleński Extracellular adenine nucleotide catabolism in heart valves Nucleosides Nucleotides Nucleic Acids 33 2014 329 332
11. D. Jin, J. Fan, L. Wang, L.F. Thompson, A. Liu, B.J. Daniel, and et al. CD73 on tumor cells impairs antitumor t-cell responses: a novel mechanism of tumor-induced immune suppression Cancer Res 70 2010 2245 2255
12. W. Kriz Adenosine and ATP: traffic regulators in the kidney J Clin Invest 114 2004 611 613
13. S.P. Colgan, H.K. Eltzschig, T. Eckle, and L.F. Thompson Physiological roles for ecto-5′-nucleotidase (CD73) Purinergic Signal 2 2006 351 360
14. H.K. Eltzschig Adenosine: an old drug newly discovered Anesthesiology 111 2009 904 915
15. J.C. Shryock, and L. Belardinelli Adenosine and adenosine receptors in the cardiovascular system: biochemistry, physiology, and pharmacology Am J Cardiol 79 1997 2 10
16. A.K. Alencar, S.L. Pereira, T.L. Montagnoli, R.C. Maia, A.E. Kümmerle, S.S. Landgraf, and et al. Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline-induced pulmonary hypertension in rats Br J Pharmacol 169 2013 953 962
17. L.S. Bergamin, E. Braganhol, F. Figueiró, E.A. Casali, R.F. Zanin, J. Sévigny, and et al. Involvement of purinergic system in the release of cytokines by macrophages exposed to glioma-conditioned medium J Cell Biochem 116 2015 721 729
18. A. Mahmut, M.C. Boulanger, R. Bouchareb, F. Hadji, and P. Mathieu Adenosine derived from ecto-nucleotidases in calcific aortic valve disease promotes mineralization through A2a adenosine receptor Cardiovasc Res 106 2015 109 120
19. Y.C. Böring, U. Flögel, C. Jacoby, M. Heil, W. Schaper, and J. Schrader Lack of ecto-5′-nucleotidase (CD73) promotes arteriogenesis Cardiovasc Res 97 2013 88 96
20. P. Koszalka, B. Ozüyaman, Y. Huo, A. Zernecke, U. Flögel, N. Braun, and et al. Targeted disruption of CD73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response Circ Res 95 2004 814 821
21. M.G. Bouma, T.M. Jeunhomme, D.L. Boyle, M.A. Dentener, N.N. Voitenok, F.A. van den Wildenberg, and et al. Adenosine inhibits neutrophil degranulation in activated human whole blood: involvement of adenosine A2 and A3 receptors J Immunol 158 1997 5400 5408
22. Y. Kawashima, T. Nagasawa, and H. Ninomiya Contribution of ecto-5′-nucleotidase to the inhibition of platelet aggregation by human endothelial cells Blood 96 2000 2157 2162
23. V. Kumar, and S.A. Adenosine An endogenous modulator of innate immune system with therapeutic potential Eur J Pharmacol 616 2009 7 15
24. G. Favero, C. Paganelli, B. Buffoli, L.F. Rodella, and R. Rezzani Endothelium and its alterations in cardiovascular diseases: life style intervention Biomed Res Int 2014 2014 801896
25. J.C. Poole, and H.W. Florey Changes in the endothelium of the aorta and the behaviour of macrophages in experimental atheroma of rabbits J Pathol Bacteriol 75 1958 245 251
26. P. Libby Inflammation and cardiovascular disease mechanisms Am J Clin Nutr 83 2006 456S 460S
27. M. Salmi, G.G. Yegutkin, R. Lehvonen, K. Koskinen, T. Salminen, and S. Jalkanen A cell surface amine oxidase directly controls lymphocyte migration Immunity 14 2001 265 276
28. L. Airas, J. Niemelä, and S. Jalkanen CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism J Immunol 165 2000 5411 5417
29. J. Niemelä, T. Henttinen, G.G. Yegutkin, L. Airas, A.M. Kujari, P. Rajala, and et al. IFN-alpha induced adenosine production on the endothelium: a mechanism mediated by CD73 (ecto-5′-nucleotidase) up-regulation J Immunol 172 2004 1646 1653
30. T. Henttinen, S. Jalkanen, and G.G. Yegutkin Adherent leukocytes prevent adenosine formation and impair endothelial barrier function by ecto-5′-nucleotidase/CD73-dependent mechanism J Biol Chem 278 2003 24888 24895
31. G.G. Yegutkin, T. Henttinen, S.S. Samburski, J. Spychala, and S. Jalkanen The evidence for two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells Biochem J 367 2002 121 128
32. S. Jalkanen, and M. Salmi Vap-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation Arterioscler Thromb Vasc Biol 28 2008 18 26
33. M. Ohta, K. Toyama, D.D. Gutterman, W.B. Campbell, V. Lemaître, R. Teraoka, and et al. Ecto-5′-nucleotidase, CD73, is an endothelium-derived hyperpolarizing factor synthase Arterioscler Thromb Vasc Biol 33 2013 629 636
34. R.J. Esper, R.A. Nordaby, J.O. Vilariño, A. Paragano, J.L. Cacharrón, and R.A. Machado Endothelial dysfunction: a comprehensive appraisal Cardiovasc Diabetol 5 2006 4
35. S. Verma, M.R. Buchanan, and T.J. Anderson Endothelial function testing as a biomarker of vascular disease Circulation 108 2003 2054 2059
36. Z. Khalpey, A.H. Yuen, M. Lavitrano, C.G. McGregor, K.K. Kalsi, M.H. Yacoub, and et al. Mammalian mismatches in nucleotide metabolism: implications for xenotransplantation Mol Cell Biochem 304 2007 109 117
37. R.T. Smolenski, Z. Khalpey, F.N. Osborne, A. Yuen, E.M. Slominska, M. Lipiński, and et al. Species differences of endothelial extracellular nucleotide metabolism and its implications for xenotransplantation Pharmacol Rep 58 Suppl. 2006 118 125
38. Z. Khalpey, A.H. Yuen, K.K. Kalsi, Z. Kochan, J. Karbowska, E.M. Slominska, and et al. Loss of ecto-5′nucleotidase from porcine endothelial cells after exposure to human blood: implications for xenotransplantation Biochim Biophys Acta 1741 2005 191 198
39. Z. Khalpey, M.H. Yacoub, and R.T. Smolenski Nucleotide metabolic mismatches in mammalian hearts: implications for transplantation Ann R Coll Surg Engl 95 2013 9 14
40. J.B. Cannata-Andia, P. Roman-Garcia, and K. Hruska The connections between vascular calcification and bone health Nephrol Dial Transplant 26 2011 3429 3436
41. P. Collin-Osdoby Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin Circ Res 95 2004 1046 1057
42. F. Rutsch, N. Ruf, S. Vaingankar, M.R. Toliat, A. Suk, W. Höhne, and et al. Mutations in ENPP1 are associated with 'idiopathic' infantile arterial calcification Nat Genet 34 2003 379 381
43. C. St Hilaire, S.G. Ziegler, T.C. Markello, A. Brusco, C. Groden, F. Gill, and et al. NT5E mutations and arterial calcifications N Engl J Med 364 2011 432 442
44. L. Hessle, K.A. Johnson, H.C. Anderson, S. Narisawa, A. Sali, J.W. Goding, and et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization Proc Natl Acad Sci U S A 99 2002 9445 9449
45. X.T. Gan, S. Taniai, G. Zhao, C.X. Huang, T.J. Velenosi, J. Xue, and et al. CD73-TNAP crosstalk regulates the hypertrophic response and cardiomyocyte calcification due to α1 adrenoceptor activation Mol Cell Biochem 394 2014 237 246
46. E. Kaniewska, A. Sielicka, P. Sarathchandra, I. Pelikant-Małecka, M. Olkowicz, E.M. Słomińska, and et al. Immunohistochemical and functional analysis of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) and ecto-5′-nucleotidase (CD73) in pig aortic valves Nucleosides Nucleotides Nucleic Acids 33 2014 305 312
47. L. Osman, A.H. Chester, M. Amrani, M.H. Yacoub, and R.T. Smolenski A novel role of extracellular nucleotides in valve calcification: a potential target for atorvastatin Circulation 114 2006 I566 I572
48. T.C. Markello, L.K. Pak, C. St Hilaire, H. Dorward, S.G. Ziegler, M.Y. Chen, and et al. Vascular pathology of medial arterial calcifications in NT5E deficiency: implications for the role of adenosine in pseudoxanthoma elasticum Mol Genet Metab 103 2011 44 50
49. N. Chassaing, L. Martin, P. Calvas, M. Le Bert, and A. Hovnanian Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations J Med Genet 42 2005 881 892
50. B. Kutryb-Zajac, P. Zukowska, M. Toczek, M. Zabielska, M. Lipinski, I. Rybakowska, and et al. Extracellular nucleotide catabolism in aortoiliac bifurcation of atherosclerotic APoE/LDLr double knock out mice Nucleosides Nucleotides Nucleic Acids 33 2014 323 328
51. A. Buchheiser, A. Ebner, S. Burghoff, Z. Ding, M. Romio, C. Viethen, and et al. Inactivation of CD73 promotes atherogenesis in apolipoprotein e-deficient mice Cardiovasc Res 92 2011 338 347
52. G.K. Hansson, and P. Libby The immune response in atherosclerosis: a double-edged sword Nat Rev Immunol 6 2006 508 519
53. A. Zernecke, K. Bidzhekov, B. Ozüyaman, L. Fraemohs, E.A. Liehn, J.M. Lüscher-Firzlaff, and et al. CD73/ecto-5′-nucleotidase protects against vascular inflammation and neointima formation Circulation 113 2006 2120 2127
54. C.E. Chadjichristos, K.E. Scheckenbach, T.A. van Veen, M.Z. Richani Sarieddine, C. de Wit, Z. Yang, and et al. Endothelial-specific deletion of connexin40 promotes atherosclerosis by increasing CD73-dependent leukocyte adhesion Circulation 121 2010 123 131
55. E.Y. Chakhtoura, F.E. Shamoon, J.I. Haft, G.R. Obiedzinski, A.J. Cohen, and R.M. Watson Comparison of platelet activation in unstable and stable angina pectoris and correlation with coronary angiographic findings Am J Cardiol 86 2000 835 839
56. E. Fuentes, J. Pereira, D. Mezzano, M. Alarcón, J. Caballero, and I. Palomo Inhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modeling PLOS ONE 9 2014 e112741
57. P.C. Burger, and D.D. Wagner Platelet P-selectin facilitates atherosclerotic lesion development Blood 101 2003 2661 2666
58. E. Fuentes, L. Badimon, J. Caballero, T. Padró, G. Vilahur, M. Alarcón, and et al. Protective mechanisms of adenosine 5′-monophosphate in platelet activation and thrombus formation Thromb Haemost 111 2014 491 507
59. T. Eckle, T. Krahn, A. Grenz, D. Köhler, M. Mittelbronn, C. Ledent, and et al. Cardioprotection by ecto-5′-nucleotidase (CD73) and A2B adenosine receptors Circulation 115 2007 1581 1590
60. L. Morabito, M.C. Montesinos, D.M. Schreibman, L. Balter, L.F. Thompson, R. Resta, and et al. Methotrexate and sulfasalazine promote adenosine release by a mechanism that requires ecto-5′-nucleotidase-mediated conversion of adenine nucleotides J Clin Invest 101 1998 295 300
61. T. Obata, S. Kubota, and Y. Yamanaka Histamine increases interstitial adenosine concentration via activation of ecto-5′-nucleotidase in rat hearts in vivo J Pharmacol Exp Ther 298 2001 71 76
62. T. Obata, and Y. Yamanaka Tyramine produces interstitial adenosine-mediated activation of ecto-5′-nucleotidase in rat heart in vivo Eur J Pharmacol 374 1999 25 31
63. F.N. Osborne, K.K. Kalsi, C. Lawson, M. Lavitrano, M.H. Yacoub, M.L. Rose, and et al. Expression of human ecto-5′-nucleotidase in pig endothelium increases adenosine production and protects from NK cell-mediated lysis Am J Transplant 5 2005 1248 1255
64. M. De Giorgi, I. Pelikant-Malecka, A. Sielicka, E.M. Slominska, R. Giovannoni, A. Cinti, and et al. Functional analysis of expression of human ecto-nucleoside triphosphate diphosphohydrolase-1 and/or ecto-5′-nucleotidase in pig endothelial cells Nucleosides Nucleotides Nucleic Acids 33 2014 313 318
65. M. De Giorgi, A. Cinti, I. Pelikant-Malecka, E. Chisci, M. Lavitrano, R. Giovannoni, and et al. Co-expression of functional human heme oxygenase 1, ecto-5′-nucleotidase and ecto-nucleoside triphosphate diphosphohydrolase-1 by Self-cleaving 2A peptide system Plasmid 79 2015 22 29